The Progress of Red Blood Cells Based Drug Delivery Systems
Journal Title: Chinese Journal of Blood Transfusion - Year 2022, Vol 35, Issue 6
Abstract
Red blood cells(RBCs), as the most abundant types of blood cells in the blood, have several advantages as a drug delivery system due to their ultra-long circulation half-life, good biocompatibility, and biodegradability. To date, a variety of RBCs-based drug delivery techniques have been developed for the treatment of infection diseases, cancers, chronic diseases, and autoimmune diseases. This review summarized the progress of RBCs related drug delivery systems, and discussed the advantages and disadvantages of different loading methods and their pre-clinical application progress, promoting the research and development of drug delivery.
Authors and Affiliations
Kehui ZHU, Hong WANG, Rui ZHONG, Ye CAO, Jiaxin LIU
Keywords
Related Articles
- EP ID EP738279
- DOI 10.13303/j.cjbt.issn.1004-549x.2022.06.021
- Views 39
- Downloads 0
Introduction to the European Guideline on Management of Major Bleeding and Coagulopathy Following Trauma (sixth edition)
In the European Guideline on Management of Major Bleeding and Coagulopathy Following Trauma updated recently, there are 39 clinical practice recommendations that follow an approximate temporal path for management of the...
Skin injury around enterostomy cured by allogeneic platelet-rich plasma: a report of two cases
Objective To investigate the feasibility of allogeneic platelet-rich plasma (PRP) for the treatment of skin injury around enterostomy. Methods The treatment process by PRP of 2 patients with skin injury around enterostom...
Assessment of infection status in treponema pallidum antibody-reactive blood donors
Objective To evaluate the infection status and potential infectivity of Treponema pallidum specific antibody (anti-TP) reactive blood donors, and to provide reference for the key prevention and screening of TP under the...
Immunogenicity of red blood cell blood group antigens in the population of Xi'an
[Objective] To evaluate the immunogenicity of red blood cell blood group antigens in the population of Xi'an. [Methods] Data on blood group antigens of voluntary blood donors from the Shaanxi Province Blood Center and un...
Regular whole blood donaion in Tianjin from 2013 to 2022
Objective To analyze the situation of regular whole blood donation in Tianjin between 2013 and 2022, in order to provide data support for improving the recruitment and retention measures of regular blood donors and ensur...